Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-20

Clinical Trial Update: Study the Effect of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Level in Hemodialysis Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating whether probiotic supplementation lowers trimethylamine-N-oxide levels in patients on hemodialysis (end-stage renal disease), cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement

Snippet

Sponsor: Al-Azhar University | Conditions: End Stage Renal Disease | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION